Worldwide glass primary packaging supplier SGD Pharma has announced the appointment of Olivier Rousseau as its new Chief Executive Officer. Olivier brings over 30 years of industrial experience to the role. He joins the business after four years as CEO & President of Verallia France, global producer of glass packaging for food and beverages, and brings a strong track record of developing strategies to support a company’s global growth.
Prior to Verallia, Olivier worked for more than 20 years at The Goodyear Tire and Rubber Company, where his roles included Chief Financial Officer of the EMEA region, managing a portfolio worth 5 billion euros. After that, Olivier lead the consumer business unit for the EMEA region, managing a portfolio with a value of 3 billion euros.
This experience will support Olivier to accelerate the implementation of SGD Pharma’s global strategy, focusing on profitable growth and high value-added products. He will also drive the company’s mission to grow both organically and through acquisition.
Commenting on his appointment, Olivier said: “I am proud to join SGD Pharma and am looking forward to supporting the business at this exciting stage in its growth trajectory. I will continue to build on the strong foundation created by all members of the global SGD Pharma team in providing customers with high quality, innovative products to meet their changing demands, while improving our industrial performance across all plants. I have a strong interest in corporate social responsibility and decarbonization and as part of our proud sponsorship into the United Nations International Year of Glass, I will be continuing our initiatives into making glass products even more sustainable for society.”
“In a market where we are having to react quickly to customer demand, due to the difficult environment the industry is currently facing, it is key that we work together to serve and deliver to our customers. I’m thrilled to be leading the team as we continue to improve our glass primary packaging offer to meet the demands of the future.”
07.07.2022, SGD Pharma
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.